NISHAN THAPA: Open Payments
NPI 1043795016 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,284 in 59 payments from 15 companies in 2025. Trend: 2023 $925 · 2024 $1,498 · 2025 $1,284
Food & beverage: $1,284
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 11 | $280 |
| Janssen Biotech, Inc. | 10 | $256 |
| ABBVIE INC. | 14 | $205 |
| Novartis Pharmaceuticals Corporation | 6 | $175 |
| Regeneron Healthcare Solutions, Inc. | 3 | $76 |
| LEO Pharma Inc. | 2 | $47 |
| Lilly USA, LLC | 2 | $44 |
| Arcutis Biotherapeutics, Inc. | 2 | $43 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $34 |
| Galderma Laboratories, L.P. | 2 | $32 |
Products named: Bimzelx, TREMFYA, COSENTYX, SKYRIZI, RINVOQ, DUPIXENT, ADBRY, Zoryve.
Industry payments across TX — which companies pay providers there.
